The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer
Open accessAbstract
Inflammatory bowel disease is an important risk factor for colorectal cancer. We show that sphingosine-1-phosphate (S1P) produced by upregulation of sphingosine kinase 1 (SphK1) links chronic intestinal inflammation to colitis-associated cancer (CAC) and both are exacerbated by deletion of Sphk2. S1P is essential for production of the multifunctional NF-κB-regulated cytokine IL-6, persistent activation of the transcription factor STAT3, and consequent upregulation of the S1P receptor, S1PR1. The prodrug FTY720 decreased SphK1 and S1PR1 expression and eliminated the NF-κB/IL-6/STAT3 amplification cascade and development of CAC, even in Sphk2(-/-) mice, and may be useful in treating colon cancer in individuals with ulcerative colitis. Thus, the SphK1/S1P/S1PR1 axis is at the nexus between NF-κB and STAT3 and connects chronic inflammation and CAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“STAT3 is also involved in inflammation-associated carcinogenesis, suppression of the antitumor immune response, and maintenance of cancer stem cells.”
From Critical analysis of the potential for targeting STAT3 in human malignancy (2013) · cites this paper as [95]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This process is critically involved in colitis-associated cancer (310).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [310]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Histone Deacetylase Inhibitors Suppress the Induction of c-Jun and Its Target Genes Including COX-2
Yamaguchi, K., Lantowski, A., Dannenberg, A. J., & Subbaramaiah, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503201200 · Cited by 80
RetractedImmunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Oshima, M., Dinchuk, J. E., Kargman, S., Oshima, H., Hancock, B. C., Kwong, E. C., Trzăskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,363
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Inflammation meets cancer, with NF-κB as the matchmaker
Ben‐Neriah, Y., & Karin, M. (2011) · Nature Immunology · doi:10.1038/ni.2060 · Cited by 1,412
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S., & Burtin, P. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3248 · Cited by 1,273
Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80005-9 · Cited by 1,220
Flagged first, then by citations
1 of the 62 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 564
Imaging S1P1 activation in vivo
Kono, M., & Proia, R. L. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.11.023 · Cited by 13
Xi, M., Wang, X., Ge, J., & Yin, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.059 · Cited by 12
Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma
Li, W., Li, J., Wang, Y., Zhang, K., Li, N., Tian, Z., Ni, B., Wang, H., & Ruan, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.13014 · Cited by 12
Role of Dietary Metabolites in Regulating the Host Immune Response in Gastrointestinal Disease
Zaatari, M. E., & Kao, J. Y. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00051 · Cited by 12
The sphingosine kinase 2 inhibitor ABC294640 inhibits cervical carcinoma cell growth
Xu, L., Jin, L., Yang, B., Wang, L., Xia, Z., Zhang, Q., & Xu, J. (2017) · Oncotarget · doi:10.18632/oncotarget.23415 · Cited by 12
Examination of the role of sphingosine kinase 2 in a murine model of systemic lupus erythematosus
Mohammed, S., Vineetha, N. S., James, S., Aparna, J. S., Lankadasari, M. B., Allegood, J. C., Li, Q., Spiegel, S., & Harikumar, K. B. (2019) · The FASEB Journal · doi:10.1096/fj.201802535r · Cited by 12
Self-citationYamashita, S., Soga, M., Nguma, E., Kinoshita, M., & Miyazawa, T. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c04562 · Cited by 12
Choi, S., Snider, J. M., Cariello, C., Lambert, J. M., Anderson, A. K., Cowart, L. A., & Snider, A. J. (2020) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2020.106423 · Cited by 12
Dmello, R. S., Palmieri, M., Thilakasiri, P. S., Doughty, L., Nero, T. L., Poh, A. R., To, S. Q., Lee, E. F., Fairlie, W. D., Mielke, L. A., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06631-8 · Cited by 11
Liu, H., Li, X., Liu, W., Zhang, C., Zhang, S., Zhou, X., Bode, A. M., & Luo, X. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119846 · Cited by 11
Pan, Y., Liu, L., Zhang, Q., Shi, W., Feng, W., Wang, J., Wang, Q., Li, S., & Li, M. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.09.020 · Cited by 11
Wu, X., Ueland, P. M., Roper, J., Koh, G. Y., Xu, L., Crott, J. W., Yilmaz, Ö. H., Bronson, R. T., & Ason, J. B. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab320 · Cited by 11
Ford, S. A., & Blanck, G. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.11.001 · Cited by 11
Xue, Y., Jiang, W., Ma, Q., Wang, X., Jia, P., Li, Q., Chen, S., Song, B., Wang, Y., Zhang, J., et al. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01262-2 · Cited by 11
Yu, B., Liang, J., Li, X., Liu, L., Yao, J., Chen, X., & Chen, R. (2022) · Molecules · doi:10.3390/molecules27165337 · Cited by 11
Self-citationWang, C., Li, Q., Song, K., Wang, W., Zhang, N., Dai, L., & Di, W. J. (2024) · Nanoscale Advances · doi:10.1039/d4na00227j · Cited by 10
Emerging discoveries on the role of TRIM14: from diseases to immune regulation
Li, X., Zhou, F., Niu, K., Wang, Y., Shi, Y., Li, Y., Gao, X. Y., Zhao, W., Chen, T., & Zhang, Y. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02276-w · Cited by 11
Plant-derived compounds for treating autosomal dominant polycystic kidney disease
Zhang, J., Chen, J., Xu, J., Xue, C., & Mao, Z. (2023) · Frontiers in Nephrology · doi:10.3389/fneph.2023.1071441 · Cited by 10
Zhang, K., Ji, J., Li, N., Yin, Z., & Fan, G. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200578 · Cited by 10
Uchino, M., Ikeuchi, H., Noguchi, T., Okabayashi, K., Futami, K., Tanaka, S., Ohge, H., Watanabe, K., Itabashi, M., Okamoto, K., et al. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16496 · Cited by 11
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases
Defendenti, C., Atzeni, F., Malandrin, S. M. I., Ardizzone, S., Almasio, P. L., Saibeni, S., Bezzio, C., Bollani, S., Salerno, R., Declich, P., et al. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.11.016 · Cited by 10
Sphingosine Kinase 1 is Associated With Immune Cell–Related Gene Expressions in Human Breast Cancer
Tsuchida, J., Nagahashi, M., Nakajima, M., Katsuta, E., Rashid, O. M., Qi, Q., Yan, L., Okuda, S., Takabe, K., & Wakai, T. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2020.06.057 · Cited by 10
Self-citationYang, J., Guan, X., He, S., Ge, L., Gao, Q., & Wu, X. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110731 · Cited by 9
The effects of STAT3 acetylation on the transcriptional activity and tumorigenesis
Yan, H., Tang, L., Zhu, Y., & Zhang, Y. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117076 · Cited by 9
Pyne, N. J., & Pyne, S. (2013) · Oncogene · doi:10.1038/onc.2013.292 · Cited by 9
Leppkes, M., Neurath, M. F., i, M. H., & Becker, C. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.5mr0515-221r · Cited by 10
Yamada, A., Spiegel, S., & Takabe, K. (2016) · Compendium of Inflammatory Diseases · doi:10.1007/978-3-7643-8550-7_197 · Cited by 9
Self-citationGendron, D. R., Lecours, P. B., Lemay, A., Beaulieu, M., Huppé, C.-A., Lee‐Gosselin, A., Flamand, N., Don, A. S., Bissonnette, É. Y., Blanchet, M., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00078 · Cited by 9
Liu, C., Wu, Y., Wang, Y., Yang, F., Ren, L., Wu, H., & Yu, Y. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.116367 · Cited by 8
Sphingolipid signaling in kidney diseases
Li, N., & Li, G. (2025) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00193.2024 · Cited by 8
Lipids: Driving Forces in the Underlying Biology of Carcinogenesis
Chakraborty, S., Kumar, A. S., & Banerjee, S. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00170 · Cited by 9
Helmy, S. A., Samaha, M. M., Salam, A. S. G. A. E., & Elrazik, N. A. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-09932-w · Cited by 8
Hafizi, R., Imeri, F., Tanturovska, B. S., Manaila, R., Schwalm, S. A., Trautmann, S., Wenger, R. H., Pfeilschifter, J. M., & Huwiler, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115882 · Cited by 8
Muñoz, J. P., Sànchez‐Fernàndez‐de‐Landa, P., Diarte‐Añazco, E. M. G., Antonio Zorzano, A., Blanco‐Vaca, F., & Julve, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087374 · Cited by 7
Nakagawa, Y., & Yamada, S. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05153-3 · Cited by 8
Ramanathan, R., Raza, A., Sturgill, J., Lyon, D., Young, J. S., Hait, N. C., & Takabe, K. (2017) · Mediators of Inflammation · doi:10.1155/2017/5984819 · Cited by 8
Self-citationPark, S. B., Choi, B.-I., Lee, B. J., Kim, N. J., Jeong, Y. A., Joo, M. K., Kim, H. J., Park, J., Kim, J. J., Noh, Y.-S., et al. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05971-2 · Cited by 8
Hodge, S. J., Macowan, M. G., Liu, H., Hamon, R., Chen, A. C. –., Marchant, J. M., Pizzutto, S. J., Upham, J. W., & Chang, A. B. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.24728 · Cited by 8
Andreassen, C. H., Lorenzen, M., Nielsen, J. E., Yahyavi, S. K., Toft, B. G., Ingerslev, L. R., Clemmensen, C., Rasmussen, L. J., Bokemeyer, C., Juul, A., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01810-w · Cited by 8
Sphingolipids and Lymphomas: A Double-Edged Sword
Pherez-Farah, A., López-Sánchez, R. C., Villela, L., Ortı́z-López, R., Beltrán, B., & Hernández-Hernández, J. A. (2022) · Cancers · doi:10.3390/cancers14092051 · Cited by 8
Suh, J. H., Makarova, A. M., Gomez, J. M., Paul, L. A., & Saba, J. D. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.07.040 · Cited by 8
Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma
Palangi, A., Shakhssalim, N., Parvin, M., Bayat, S., & Allameh, A. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02049-3 · Cited by 8
Enteric nervous system and inflammatory bowel disease
Wang, S., Wang, Y., Miao, J., Zheng, X., Ge, W., Chen, G., & Yin, Y. B. (2026) · Gastroenterology report · doi:10.1093/gastro/goag005 · Cited by 8
Yang, P., Li, Z., Zhang, L., Li, H., & Li, Z. (2016) · RSC Advances · doi:10.1039/c6ra01718e · Cited by 7
Cerebral conditioning: Mechanisms and potential clinical implications
Sheng, R., Chen, J., & Qin, Z. (2021) · Brain Hemorrhages · doi:10.1016/j.hest.2021.08.003 · Cited by 7
Li, M., Liu, J., La, C., Liu, T., Zhao, Z., Wang, Z., Dai, M., Chen, J., Ren, Z., Ye, C., et al. (2023) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2023.105050 · Cited by 7
Taylor, O. B., DeGroff, N., El‐Hodiri, H. M., Gao, C., & Fischer, A. J. (2024) · eLife · doi:10.7554/elife.102151.4 · Cited by 8
GPI-anchored serine proteases: essential roles in development, homeostasis, and disease
Lundgren, J. G., Flynn, M. G., & List, K. (2025) · Biological Chemistry · doi:10.1515/hsz-2024-0135 · Cited by 6
Lipid metabolic reprogramming in colorectal cancer: Insights to mechanisms and therapeutics
Wang, C.-D., Zhang, B., & Song, J. (2025) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v17.i10.109398 · Cited by 7
An inducible sphingosine kinase 1 in hepatic stellate cells potentiates liver fibrosis
Baek, J. S., Lee, J. H., Kim, J. H., Cho, S. S., Cho, S. S., Yang, J. H., Shin, E. J., Kang, H., Kim, S., Ahn, S., et al. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116520 · Cited by 6
Zhang, Y., Chen, J., Zhao, Y., Weng, L., & Xu, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.562574 · Cited by 6
Skibbe, K., Brethack, A.-K., Sünderhauf, A., Ragab, M., Raschdorf, A., Hicken, M., Schlichting, H., Preira, J., Brandt, J., Castven, D., et al. (2021) · Cancers · doi:10.3390/cancers13225817 · Cited by 6
Olesch, C., Brüne, B., & Weigert, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031289 · Cited by 6
Mao, Y., Wang, J., Zhao, Y., Yan, R., Li, H., Chen, C., Lee, R. J., Byrd, J. C., Lee, L. J., Muthusamy, N., et al. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.05.022 · Cited by 6
Understanding Colorectal Cancer: The Basics
Ghanta, M. K., Gursale, S. C., & Bhaskar, L. V. (2020) · Diagnostics and therapeutic advances in GI malignancies · doi:10.1007/978-981-15-2017-4_7 · Cited by 6
S1P Lyase Regulates Intestinal Stem Cell Quiescence via Ki-67 and FOXO3
Schwiebs, A., Faqar-Uz-Zaman, F., Juan, M. H. S., & Radeke, H. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115682 · Cited by 6
Dash, R. P., Srinivas, N. R., & Rais, R. (2017) · Biomedical Chromatography · doi:10.1002/bmc.4109 · Cited by 6
S1PR3 mediates itch and pain via distinct TRP channel-dependent pathwaysPreprint
Hill, R. Z., Morita, T., Brem, R. B., & Bautista, D. M. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/235614 · Cited by 6
Li, D., Tao, H., Tan, X., Ling, H., Lu, Y., Zhang, H., Theany, S., & Xu, H. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1643209 · Cited by 5
Wang, X., Zhao, M., Xia, G., Shi, H., Li, C., Shen, X., Rakariyatham, K., He, S., Liu, Z., & Zhou, D. (2024) · Food Frontiers · doi:10.1002/fft2.450 · Cited by 5
The role of ACER2 in intestinal sphingolipid metabolism and gastrointestinal cancers
Liu, B., Junfeng, Z., Jiang, B., Tang, B., Liu, T., & Lei, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1511283 · Cited by 5
Nagahashi, M., Komatsu, M., Urano, S., Kuroiwa, M., Takahashi, Y., Morimoto, K., Pradipta, A. R., Tanaka, K., & Miyoshi, Y. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0023 · Cited by 5
Self-citationMeng, S., Kang, K., Fei, D., Yang, S., Pan, S., Yu, K., & Zhao, M. (2022) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.21-0160 · Cited by 5
Martín‐Hernández, D., Gutiérrez, I. L., González‐Prieto, M., MacDowell, K. S., Robledo‐Montaña, J., Tendilla‐Beltrán, H., Calleja-Rodríguez, N., Bris, Á. G., Ulecia-Morón, C., Moreno, B., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-08011-8 · Cited by 5
Yan, J., Chen, Y., Wu, Q., Shao, L., & Zhou, X. (2022) · Oncology Letters · doi:10.3892/ol.2022.13361 · Cited by 5
Niu, L., Liu, L., & Cai, J. (2023) · Frontiers in Surgery · doi:10.3389/fsurg.2023.1079129 · Cited by 5
Taylor, O., Kelly, L. E., El‐Hodiri, H. M., & Fischer, A. J. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.0150-25.2025 · Cited by 4
Rachma, B., Pamungkas, R. P., Sandra, D. Y., Sutanto, H., & Fetarayani, D. (2025) · Clinical Immunology Communications · doi:10.1016/j.clicom.2025.11.004 · Cited by 4
Fang, J., Wang, X., Su, X., Li, D., Wang, F., Wang, P., Yuan, C., Ji, F., Zhang, D., Cai, X., et al. (2025) · The Innovation Life · doi:10.59717/j.xinn-life.2025.100164 · Cited by 7
Zhao, J., Zhao, W., & Yu, Z. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70432 · Cited by 4
Chen, Y., Zhong, Z., Deng, Y., Lu, Y., & Qin, X. Y. (2024) · Biomedical Chromatography · doi:10.1002/bmc.5837 · Cited by 4
Janneh, A. H. (2024) · BioChem · doi:10.3390/biochem4020007 · Cited by 4
Kim, S., Shin, M. W., Jin, B. C., Seo, S. Y., & Kim, S. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09091-y · Cited by 4
Groner, B., & Vafaizadeh, V. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.08.019 · Cited by 4
TNF-α: A Benificial or Harmful Pathogenic Cytokine in Cardiovascular System
Dhiman, S., Kumar, I., Palia, P., Jamwal, S., & Kumar, P. (2021) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v11i1.4507 · Cited by 5
Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer
Velazquez, F. N., Zhang, L., Viscardi, V., Trocchia, C., Hannun, Y. A., Obeid, L. M., & Snider, A. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252311 · Cited by 4
Pharmacogenetics and Pharmacogenomics Impact on Aspirin Response
Siddiqui, M. A., Jain, C., Usmani, A., Hafeez, A., Khalid, M., & Mujahid, M. (2024) · Pharmaceutical science. · doi:10.5772/intechopen.113026 · Cited by 5
Nema, R., Pandey, R., & Kumar, A. (2024) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2024.25.3.725 · Cited by 4
Mucci, B., Palazzolo, E., Ruberti, F., Ientile, L., Natale, M. F., & Esposito, S. (2026) · Pharmaceuticals · doi:10.3390/ph19010176 · Cited by 3
Sphingosine kinase activity and sphingosine‐1‐phosphate in the inflamed human periodontium
Hamdan, N., Bhagirath, A. Y., & Júnior, E. L. B. (2021) · Oral Diseases · doi:10.1111/odi.13995 · Cited by 3
Wollny, T., Wnorowska, U., Piktel, E., Suprewicz, Ł., Król, G., Głuszek, K., Góźdź, S. S., Kopczyński, J., & Bucki, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137443 · Cited by 3
Vellecco, V., Esposito, E., Indolfi, C., Saviano, A., Panza, E., Bucci, M., Brancaleone, V., Cirino, G., Bianca, R. D. D. V., Sorrentino, R., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115536 · Cited by 3
Sphingolipids in Intestinal Inflammation and Tumorigenesis
Garcı́a-Barros, M., Coant, N., & Snider, A. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-19986-3_9 · Cited by 3
Molecular mechanisms of intestinal inflammation leading to colorectal cancer
Shastri, S., Vemuri, R., Gueven, N., Shastri, M. D., & Eri, R. D. (2017) · AIMS Biophysics · doi:10.3934/biophy.2017.1.152 · Cited by 3
Sciberras, P., Grech, L., & Grech, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10214999 · Cited by 4
Acetylsalicylsäure und Prävention kolorektaler Karzinome
Schrör, K., & Rauch, B. H. (2013) · Der Internist · doi:10.1007/s00108-013-3311-y · Cited by 3
Lippi, B. K., Fernandes, G. A. B., Azevedo, G. A., Negreiros, N. G. S., Soares, A., Landgraf, M. A., Fernandes, J. P. S., & Landgraf, R. G. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112128 · Cited by 2
Advances in ORMDL Research in Malignant Tumors: A Review
Wang, H., Yi, Z., Yan, S., Wang, Y., Zhang, W., Guo, R., Li, Y., Wang, R., Li, H., Li, X., et al. (2025) · OncoTargets and Therapy · doi:10.2147/ott.s537194 · Cited by 2
Yang, X., Song, X., Zhu, F., Xia, Y., Cao, J., Chen, J., & Zhao, Z. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120868 · Cited by 2
Medical Application of In-cell Reactions with Acrolein in Cancer
Pradipta, A. R., Takahashi, Y., Terashima, K., Ode, Y., & Tanaka, K. (2026) · Journal of Synthetic Organic Chemistry Japan · doi:10.5059/yukigoseikyokaishi.84.29 · Cited by 2
Bi, Z., Chang, X., Zhu, S., Fu, S., Zhang, Y., Wang, T., Wang, F., Zhuang, H., & Hua, Z. (2026) · Science Advances · doi:10.1126/sciadv.adz2892 · Cited by 2
Bahaa, M. M., Abdallah, M. S., Mosalam, E. M., Gardouh, A. R., Nazih, M., Hamza, E., Al-Dhelaan, R. A., & Kamal, N. (2026) · Inflammopharmacology · doi:10.1007/s10787-025-02101-5 · Cited by 2
The Dual Faces of S1P: Orchestrating Immune Responses in Health and Disease
Mills, S. A., Barr, D., Mehrotra, S., & Chakraborty, P. (2026) · Cells · doi:10.3390/cells15080663 · Cited by 2
The Role of Lysophospholipids in Immune Cell Trafficking and Inflammation
Miyasaka, M., Takeda, A., Hata, E., Sasaki, N., Umemoto, E., & Jalkanen, S. (2016) · Springer eBooks · doi:10.1007/978-4-431-56068-5_35 · Cited by 2
Chang, Y., Liu, H., Chuang, H.-L., Liao, J., Kao, P.-L., Chan, H.-L., Chen, T.-H., & Wang, Y. (2023) · Laboratory Animal Research · doi:10.1186/s42826-023-00180-5 · Cited by 2
Li, P., Hu, H., Yang, L., Zhong, L. L. D., Sun, B., & Bao, C. (2025) · Mediators of Inflammation · doi:10.1155/mi/1619237 · Cited by 2
Neurite outgrowth inhibitor-B in physiology and disease
Tan, W., Long, D. A., & Gnudi, L. (2025) · Physiological Reviews · doi:10.1152/physrev.00052.2024 · Cited by 2
Anti-immigrant sentiments, actions and policies: the North American region and the European Union
Verea, M. (2012) · Dialnet (Universidad de la Rioja) · Cited by 2
Vishwakarma, S., Joshi, D., Pandey, R., Das, S., Mukhopadhyay, S., Singh, R., Singhal, R., Kapoor, N., & Kumar, A. (2022) · Cureus · doi:10.7759/cureus.23553 · Cited by 2
Dietary patterns and the neoplastic‐prone tissue landscape of old age
Marongiu, F., & Laconi, E. (2020) · Aging and Cancer · doi:10.1002/aac2.12021 · Cited by 2
Metadata
- Authors
- Liang, J., Nagahashi, M., Kim, E. Y., Harikumar, K. B., Yamada, A., Huang, W.-C., Hait, N. C., Allegood, J. C., Price, M. M., Avni, D., Takabe, K., Kordula, T., Milstien, S., & Spiegel, S.
- Affiliations
- Virginia Commonwealth University (US)
- Corresponding author
- Spiegel, Sarah
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 23
- Issue
- 1
- Pages
- 107-120
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3578577
- OpenAlex
- W2145876349
- Cited by
- 563
- References
- 62
- Citations by year
- 2026: 21 · 2025: 29 · 2024: 35 · 2023: 20 · 2022: 37 · 2021: 45 · 2020: 51 · 2019: 42 · 2018: 44 · 2017: 57 · 2016: 59 · 2015: 48 · 2014: 48 · 2013: 25
- FWCI
- 15.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Susan G. Komen
- National Institutes of Health (5k12hd055881-05)
- Japan Society for the Promotion of Science
- National Heart, Lung, and Blood Institute (T32HL094290)
- National Cancer Institute (P30CA16059, R01CA160688, R01CA-61774, R01CA061774, P30CA016059)
- National Institute of General Medical Sciences (R37GM043880)
- National Institute of Allergy and Infectious Diseases (U19AI077435)
- National Institute of Neurological Disorders and Stroke (P30NS047463)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12-HD055881)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- sphingosine-1-phosphate, sphingosine kinase 1, sphingosine kinase 2, S1PR1, STAT3 activation, NF-κB, interleukin-6, colitis-associated colorectal cancer, inflammatory bowel disease, ulcerative colitis, fingolimod, chronic intestinal inflammation, colorectal cancer
- MeSH terms
- Fingolimod Hydrochloride, Sphingosine Kinase, Animals, Cell Transformation, Neoplastic, Colitis, Colon, Lysophospholipids, Propylene Glycols, Sphingosine, Interleukin-6, Gene Expression Regulation, Neoplastic, NF-kappa B, Gene Deletion, Phosphotransferases (Alcohol Group Acceptor), STAT3 Transcription Factor, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review